Sernova (SEOVF) Stock Price, News & Analysis

Company Overview

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Key Stats

• Today's Range: $0.15 to $0.15
• 50-Day Range: $0.15 to $0.18
• 52-Week Range: $0.14 to $0.51
• Volume: 9,708 shs
• Average Volume: 39,154 shs
• Market Capitalization: $49.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.50
• Consensus Rating: Hold

SEOVF Stock Analysis - Frequently Asked Questions

How have SEOVF shares performed this year?

Sernova's stock was trading at $0.15 at the start of the year. Since then, SEOVF shares have increased by 0.3% and is now trading at $0.1505.
View the best growth stocks for 2025 here.

How were Sernova's earnings last quarter?

Sernova Corp. (OTCMKTS:SEOVF) posted its quarterly earnings data on Monday, December, 23rd. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Sernova?

Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 12/23/2024
• Today: 1/21/2025
• Next Earnings (Estimated): 3/17/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SEOVF
• CUSIP: N/A
• CIK: 1491434
• Web: www.sernova.com
• Phone: (519) 858-5184
• Fax: 519-858-5184
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.50
• High Stock Price Target: $1.50
• Low Stock Price Target: $1.50
• Potential Upside/Downside: +896.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-23,650,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -479.95%
• Return on Assets: -283.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.32
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -5.02

Miscellaneous

• Outstanding Shares: 328,480,000
• Free Float: N/A
• Market Cap: $49.44 million
• Optionable: Not Optionable
• Beta: 1.17